Blumox CA (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Blue Cross Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Amoxicillin Trihydrate, Clavulanate Potassium. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 56 (arround $0.784 US Dollar)
Generic (Salt) Combination :
(Amoxicillin Trihydrate+ Clavulanate Potassium)
Pharma Company :
Blue Cross Laboratories Ltd.
Brand Label :
Blumox CA (30 ml)
Preparation Type :
Syrup
Single Dose :
5 ml
Composition (Fixed-Dose Combination) :
Amoxicillin Trihydrate-200 mg
Clavulanate Potassium-28.5 mg
Pack Size/Qty/Vol :
30 ml
Price Unit :
Rs 9.33 INR (arround $0.13062 US Dollar)
Price Pack :
Rs 56 INR (arround $0.784 US Dollar)
Drug details for Blumox CA (30 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Blumox CA (30 ml) are :
Amoxicillin Trihydrate-200 mg
Clavulanate Potassium-28.5 mg
Amoxicillin Trihydrate Indication (Prescribed for or used as):
For more details on Amoxicillin Trihydrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amoxicillin Trihydrate..
Clavulanate Potassium Indication (Prescribed for or used as):
For more details on Clavulanate Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanate Potassium..
Blumox CA (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 6 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Blumox CA (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Amoxicillin Trihydrate-200 mg Clavulanate Potassium-28.5 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.